% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Handke:282509,
      author       = {A. E. Handke and M. Ritter and P. Albers$^*$ and J. Noldus
                      and J. P. Radtke$^*$ and P. Krausewitz},
      title        = {{P}rostate cancer-multiparametric {MRI} and alternative
                      approaches in intervention and therapy
                      planning.[{M}ultiparametrische {MRT} und alternative
                      {M}ethoden in der {I}nterventions- und {B}ehandlungsplanung
                      beim {P}rostatakarzinom].},
      journal      = {Die Urologie},
      volume       = {62},
      number       = {11},
      issn         = {2731-7064},
      address      = {New York]},
      publisher    = {Springer Medizin},
      reportid     = {DKFZ-2023-01798},
      pages        = {1160-1168},
      year         = {2023},
      note         = {2023 Nov;62(11):1160-1168},
      abstract     = {In recent years, multiparametric magnetic resonance imaging
                      (mpMRI) of the prostate has gained importance and plays a
                      crucial role in both personalized diagnostics and
                      increasingly in the treatment planning for patients with
                      prostate cancer.The aim of this study is to present
                      established and innovative applications of MRI in the
                      diagnosis and treatment of localized prostate cancer,
                      evaluating their strengths and weaknesses. Furthermore, it
                      will explore alternative approaches and compare them in a
                      comprehensive manner.A systematic literature review on the
                      application of mpMRI for biopsy and therapy planning was
                      conducted.The integration of modern imaging techniques,
                      especially mpMRI, into the diagnostic algorithm has
                      revolutionized prostate cancer diagnosis. MRI and MRI-guided
                      biopsy detect more significant prostate cancer, with the
                      potential to reduce unnecessary biopsies and the diagnosis
                      of clinically insignificant carcinomas. In addition, MRI
                      provides crucial information for risk stratification and
                      treatment planning in prostate cancer patients, both before
                      radical prostatectomy and during active
                      surveillance.Multiparametric MRI offers significant added
                      value for the diagnosis and treatment of localized prostate
                      cancer. The advancement of MRI analysis, such as the
                      implementation of artificial intelligence algorithms, holds
                      the potential for further enhancing imaging diagnostics.},
      subtyp        = {Review Article},
      keywords     = {Active surveillance (Other) / Biopsy (Other) / Quality
                      assurance (Other) / Risk stratification (Other) /
                      Ultrasonography (Other)},
      cin          = {C130 / E010},
      ddc          = {610},
      cid          = {I:(DE-He78)C130-20160331 / I:(DE-He78)E010-20160331},
      pnm          = {315 - Bildgebung und Radioonkologie (POF4-315)},
      pid          = {G:(DE-HGF)POF4-315},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:37666944},
      doi          = {10.1007/s00120-023-02190-6},
      url          = {https://inrepo02.dkfz.de/record/282509},
}